|
|
|
| Clinical diagnosis value of serum anti-Mullerian hormone combined with sex hormone detection for polycystic ovary syndrome |
| ZHONG Lei1 XIAO Zuomiao1 LIU Yan2 XIE Haiyan1 QIU Yumei1 |
| 1. Department of Clinical Laboratory, People′s Hospital of Ganzhou City
2. Department of Reproduction, People′s Hospital of Ganzhou City |
|
|
|
|
Abstract Objective To investigate the clinical diagnostic value of serum anti-Mullerian hormone (AMH) combined with follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) detection for polycystic ovary syndrome (PCOS). Methods Clinical data of 50 PCOS patients admitted to People′s Hospital of Ganzhou City from June 2018 to June 2019 were retrospectively analyzed and included in the PCOS group. In addition, 30 other infertility patients admitted to People′s Hospital of Ganzhou City during the same period were selected as the other infertility group,and 30 healthy patients who underwent routine physical examination during the same p eriod were selected as the healthy control group. The levels of AMH, FSH, LH and T in all the selected subjects were examined, and the levels of AMH and sex hormones in the three groups were compared. Receiver operating characteristic (ROC) curves were drawn to analyze the clinical value of single and combined detection of AMH, FSH, LH and T in the diagnosis of PCOS. Results The levels of AMH, FSH, LH and T in PCOS group were higher than those in other infertility groups and healthy control group, and the levels of AMH, FSH, LH and T in other infertility groups were higher than those in control group, the differences were statistically significant (P＜0.05). ROC curve results showed that the areas under the curve of AMH, FSH, LH and T were 0.720, 0.693, 0.534, 0.703 and 0.989 respectively for the diagnosis of PCOS, which had certain diagnostic efficiency, and the combined detection had the highest diagnostic efficiency. Conclusion The use of AMH combined with FSH, LH and T in the diagnosis of PCOS patients has high application value, which can increase the disease detection rate and provide more reference for clinical diagnosis.
|
|
|
|
|
|
| [1] |
范凯慧，李江.血清AMH 联合PSA 检测对多囊卵巢综合征的辅助诊断价值[J].检验医学与临床，2020，17（20）：2971-2974.
|
| [2] |
张红阳，侯丽辉.多囊卵巢综合征患者LH/FSH 比值与临床及生化水平的相关性[J].医学研究杂志，2019，48（6）：64-67.
|
| [3] |
张琳，岳喻伦，闫莉，等.血清抗苗勒管激素检测对多囊卵巢综合征的诊断意义[J].川北医学院学报，2019，34（5）：635-638.
|
| [4] |
卿朝晖.多囊卵巢综合征患者睾酮水平与卵巢超声检测指标的关系分析[J].中国医学创新，2019，16（14）：107-110.
|
| [5] |
崔雄鹰，胡杰，阴振晨，等.多囊卵巢综合征患者血清相关性腺激素结果分析[J].标记免疫分析与临床，2019，26（8）：1282-1285.
|
| [6] |
韩晓洁，商文金.抗苗勒氏管激素在不同卵巢储备功能患者的表达及相关性分析[J].中国妇产科临床杂志，2019，20（4）：358-360.
|
| [7] |
周良燕，郑幽冰.PCOS 患者INHB、AMH 及各项内分泌指标分析[J].中国妇幼保健，2019，34（19）：4419-4421.
|
| [8] |
翟庆娜，刘芹兰，路瑞静，等.多囊卵巢综合征患者血清AMH、TNF-α、T、DHEA-S 的水平及临床意义[J].海南医学，2020，31（9）：1100-1102.
|
| [9] |
张倩岚，岳朝艳，应春妹.血清AMH 与抑制素B 检测对多囊卵巢综合征的辅助诊断应用[J].中华检验医学杂志，2019，42（8）：652-656.
|
| [10] |
赵建藏，赵印青，张岭山，等.血清AMH 水平联合FSH/LH 预测PCOS 不孕症促排卵效果和妊娠率的临床[J].中国优生与遗传杂志，2020，28（5）：595-598，643.
|
| [11] |
贺侠琴，孙桂荣，王汝琨，等.血清抗缪勒管激素与性激素联合检测对多囊卵巢综合征的诊断价值[J].中华检验医学杂志，2018，41（6）：456-461.
|
| [12] |
范芸，解娟，施瑞洁，等.抗苗勒氏管激素和卵泡刺激素对多囊卵巢综合征的诊断效能研究[J].中国临床药理学杂志，2019，35（21）：2665-2667.
|
| [13] |
陈倩，傅亚富.抗苗勒管激素在多囊卵巢综合征中的临床应用[J].中国卫生检验杂志，2018，28（2）：212-214.
|
| [14] |
唐婕，吴韶清，许遵鹏，等.血清抗苗勒氏管激素水平在多囊卵巢综合征患者中的诊断价值[J].热带医学杂志，2019，19（11）：1386-1388.
|
| [15] |
杜静，李嘉丽，晏耀明，等.多囊卵巢综合征患者血清AMH、LH 和FSH 水平检测及临床应用研究[J].现代检验医学杂志，2019，34（5）：68-71.
|
| [16] |
钟兴明，秦爽，殷倩，等.抗米勒管激素对多囊卵巢综合征的诊断价值及其与临床特征相关性分析[J].中国实用妇科与产科杂志，2020，36（10）：1007-1011.
|
| [17] |
刘鹏，荀巧巧.抗苗勒管激素联合性激素用于多囊卵巢综合征诊断的临床价值[J].中国基层医药，2020，27（16）：1979-1983.
|
| [18] |
陈建芳，陆秋静.抗苗勒管激素和内分泌代谢指标在诊断多囊卵巢综合征中的特异度和灵敏度分析[J].中国妇幼保健，2021，36（2）：371-374.
|
| [19] |
黄春月，侯丽辉，杨光，等.抗米勒管激素水平与多囊卵巢综合征患者代谢指标的相关性分析[J].世界中医药，2021，16（14）：2171-2176.
|
| [20] |
顾金明，张文渊.性激素与抗缪勒氏管激素联合检测诊断多囊卵巢综合征的应用分析[J].浙江临床医学，2021，23（6）：883-884，887.
|
| [21] |
王静.多囊卵巢综合征患者性激素、血脂、体重指数与抗缪勒氏管激素异常的相关性分析[J].中国当代医药，2020，27（25）：190-193.
|
| [22] |
兰云竹，毛熙光.抗苗勒管激素在不同年龄段女性生育功能预测中的运用价值探讨[J].中国医药科学，2020，10（3）：13-17.
|
|
|
|
